Skip to main content
Toggle navigation
Login
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
G
Garlick, Russell
LGC
MRD’s Next Decade: Improving Accuracy and Precision of Tumor-Informed MRD to Standardizing Epigenetics and Fragmentomics for Tumor Agnostic MRD
Location: 152, Level 1
Russell Garlick
Gass, Jennifer
Florida Cancer Specialists & Research Institute
Implementing and Scaling In-house Genomic Testing: Insights from an Independent Medical Oncology Practice
Location: 157AB, Level 1
Jennifer Gass
Giandrea, Ray
Maine Molecular Quality Controls, Inc.
Confidence in Every Result: Tools & Insights for Molecular Lab Success
Location: 157C, Level 1
Ray Giandrea
Gibson, Jane
Univ of Central Florida College of Medicine
What Does a Provider Friendly NGS Molecular Biomarker Report Look Like?
Location: Innovation Spotlight Stage #3
Jane Gibson
AMP Working Group: Developing a More Patient-Friendly NGS Molecular Biomarker Report
Location: 156ABC, Level 1
Jane Gibson
Gillette, Michael
Broad Institute of MIT and Harvard
Proteomic Approaches to Molecular Diagnostics
Location: 253ABC, Level 2
Michael Gillette
Glenn, Sean
Roswell Park Comprehensive Cancer Center
Harnessing NGS-based MRD detection: Insights from a retrospective AML cohort study
Location: 156AB, Level 1
Sean Glenn
Goar, Wesley
Nationwide Children's Hospital
Developing Robust Bioinformatic Pipelines and Regulatory Requirements
Location: 156ABC, Level 1
Wesley Goar
Godsey, Jim
BLOODPAC
Demystifying MRD with BloodPac: Navigating Clinical and Technical Pathways for Comprehensive Cancer Monitoring
Location: 156AB, Level 1
Jim Godsey
MRD’s Next Decade: Improving Accuracy and Precision of Tumor-Informed MRD to Standardizing Epigenetics and Fragmentomics for Tumor Agnostic MRD
Location: 152, Level 1
Jim Godsey
Goldberg, PhD, Michael
AI-Data-Driven Trial Design: Advanced Digital Models and Multimodal Testing Tools
Location: Innovation Spotlight Stage #2
Michael Goldberg, PhD
Golkaram, Mahdi
Roche Diagnostics Solutions
Sequencing by Expansion (SBX), a Versatile, High-Throughput Single-Molecule Sequencing Technology for a Variety of Applications
Location: 151AB, Level 1
Mahdi Golkaram
Gonzalez, Dimitri
ABL Diagnostics S.A.
Advances in Ultra-Sensitive Genomic Technologies for Cancer and Infectious Disease Diagnostics.
Location: 160B, Level 1
Dimitri Gonzalez
Gonzalez-Ferrer, Shekina
UCLA Health
(ID036) 16S/ITS Targeted NGS for Pathogen Detection in Plasma
Shekina Gonzalez-Ferrer
Gonzaludo, Nina
Transforming Clinical Genomics with Long-Read Sequencing
Location: Innovation Spotlight Stage #1
Nina Gonzaludo
Goswami, Rashmi
University of Toronto
AMP Working Group: Molecular Testing for Measurable Residual Disease Testing in Acute Myeloid Leukemia
Location: 156ABC, Level 1
Rashmi Goswami
Graham, Trevor
Institute of Cancer Research, London, UK
Fluctuating DNA methylation and evolutionary history in lymphoid cancers
Location: 156ABC, Level 1
Trevor Graham
Greene, Dina
University of Washington
Self-Collection: Navigating the Variables and Balancing the Pros and Cons
Location: 253ABC, Level 2
Dina Greene
Greiner, Tim
University of Nebraska Medical Center
AMP Working Group: Application of NGS of Immunoglobulin Heavy Chain and T-cell Receptor Gamma Gene Rearrangements for Clonality Assessment in Lymphoid Malignancies
Location: 153ABC, Level 1
Tim Greiner
Griffin, Gabriel
Dana-Farber Cancer Institute
Rapid Epigenomic Classification of Acute Leukemia
Location: 157ABC, Level 1
Gabriel Griffin
Griffith, Malachi
Washington University
Leveraging RNA Sequencing for Splice Variant Discovery and Somatic Variant Prioritization in Precision Oncology
Location: 153ABC, Level 1
Malachi Griffith
Guan, Nick
Fapon Biotech Inc.
Shaping the Future of Molecular Testing—Innovative Enzymes at the Core
Location: 152, Level 1
Nick Guan
Guzzetta, Alexander
University of Chicago
(TT008) Century-Scale Archival Sequencing of Colorectal Cancer Through a Shifting Disease Landscape
Alexander Guzzetta
